MedTrace Logo

OSPM-Enhanced AI Model to Identify Premalignant and Malignant Ocular Surface Tumors

NCT06567028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-03-26

No results posted yet for this study

Summary

An OSPM-enhanced deep learning model has been developed for identifying premalignant and malignant tumors using data retrospectively collected from the Ningbo Eye Hospital, Jiangdong Eye Hospital, and the Eye Hospital of Wenzhou Medical University. To further substantiate the model's effectiveness, we intend to evaluate it prospectively at Ningbo Eye Hospital.

Conditions

  • Performance of the Model

Interventions

DIAGNOSTIC_TEST

OSPM-Enhanced AI Model

Analyze tumor images using the model developed in our study

Sponsors & Collaborators

  • Ningbo Eye Hospital

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2024-10-01
Completion
2024-11-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06567028 on ClinicalTrials.gov